Fortress Biotech, Inc. Operating Leases, Future Minimum Payments, Due in Four and Five Years
Fortress Biotech, Inc. (FBIO) had Operating Leases, Future Minimum Payments, Due in Four and Five Years of $2.77 million as of 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears · last filed 2016-03-15
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Four and Five Years $2.77M.
| Period end | Operating Leases, Future Minimum Payments, Due in Four and Five Years |
|---|---|
| 2015-12-31 | $2.77M 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |